“A new study introduces research progress in the field of antipsychotic-induced movement disorders (AIMDs). Experts conducted a genome-wide association study (GWAS) across multiple cohorts, identifying key genetic loci associated with AIMDs. The findings highlight the role of substantia nigra related gene polymorphisms in AIMDs, opening a new direction for personalized treatment approaches in schizophrenia.”